<DOC>
	<DOCNO>NCT00002969</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . PURPOSE : Phase II trial study effectiveness chemotherapy paclitaxel treat patient stage IIIB stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>S9714 : Paclitaxel Treating Patients With Stage IIIB Stage IV Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : I. Assess survival , progression-free survival response rate patient bronchioloalveolar carcinoma receive paclitaxel . II . Evaluate toxic effect paclitaxel 96 hour continuous infusion patient . OUTLINE : Patients receive 6 cycle paclitaxel IV continuous infusion 96 hour . Before cycle 4 , restaging perform . If disease progression witness , patient remove study . If stable , partial , complete response observe , patient receive total 6 cycle . Three week last cycle , final restaging perform . Patients follow every 3 month treatment every 6 month thereafter , unless frequent follow-up clinically recommend . PROJECTED ACCRUAL : 50 patient enrol . The accrual rate estimate 25 per year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically proven Stage IIIB IV bronchioloalveolar nonsmall cell lung carcinoma incompletely resect unresectable tumor may multifocal diffuse measurable evaluable disease require No prior brain metastasis PATIENT CHARACTERISTICS : Age : 18 Performance Status : SWOG 02 Life Expectancy : Not specify Hematopoietic : Absolute granulocyte count least 1,500/mm3 Platelet count least 100,000/mm3 Hepatic : Bilirubin great institutional upper limit normal ( ULN ) SGOT great 2 time ULN Renal : Creatinine great institutional ULN OR creatinine clearance least 50 mL/min Other : Not pregnant nursing Effective contraceptive method use study No prior malignancy allow , except : basal squamous cell skin cancer situ cervical cancer Stage I II cancer remission Any cancer patient disease free 5 year PRIOR CONCURRENT THERAPY : Biologic therapy : No prior biologic therapy lung cancer Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior radiation therapy ( include palliative radiotherapy ) Surgery : Prior surgery allow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>